Episode notes
Join us this episode for a conversation with Dr. Michael Fehlings, the most cited neurosurgeon ever on the topic of spinal cord injury (https://doi.org/10.1038/s41393-021-00691-9), for a conversation about the pharmaceutical agent riluzole for the treatment of acute spinal cord injury (SCI). Dr. Fehlings walks us through the past, present, and future of this drug that has proven efficacy in other neurological conditions and that might serve an important role in initial phases of treating SCI. We trust you'll enjoy this conversation about riluzole from the source of a principal investigator physician-scientist studying it from its inauguration in SCI.